Global Cell Culture Media Market, Forecast 2028A Story by Kavita Krishna Cell Culture Media Market by Payment Method, Vertical - Global Forecast to 2028 Bharat Book Bureau Provides the Trending Market Research Report on “Cell Culture Media Market by Payment Method, Vertical - Global Forecast to 2028”under Life Sciences Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports. The global Cell Culture Media Market is projected to reach USD 13.0 billion by 2028 from USD 6.2 billion in 2023, at a CAGR of 16.0% during the forecast period. Rising demand for mabs & biosimilars, increased adoption of serum-free media are some of the major factors projecting the market growth. Increased adoption of cell-based vaccines coupled with rise in investment by key market players in launch of novel products in the market are some of the major elements anticipated to drive the market growth in coming years. 
“By type, the serum-free media segment is projected to grow at significant CAGR during the forecast period” In 2022, the serum-free media segment accounted for the largest share of the market. Serum-free media has been developed as an alternative to serum-containing media to provide a more controlled and defined environment for cell culture. These media are usually composed of a basal medium supplemented with defined concentrations of growth factors, hormones, vitamins, minerals, and other nutrients necessary for cell growth and proliferation. Due to various advantages there has been increased demand for serum-free media among end users, this factor is impacting the segmental growth. “Asia Pacific: The fastest-growing region in the cell culture media market” The cell culture media market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific market is expected to register the highest CAGR of 17.5% during the forecast period. Favorable regulatory support and guidelines for the cell culture-based vaccine production, moderate manufacturing costs of vaccines and emphasis on geographical expansion by key market players in the region are some of the major factors anticipated to project the growth of the Asia Pacific region at faster pace. A breakdown of the primary participants referred to for this report is provided below: The prominent players in the global cell culture media market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US), Caisson Laboratories Inc. (US), PromoCell GmbH (Germany), Cell Biologics, Inc. (US), InvivoGen (France), PAN-Biotech GmbH (Germany), Cellular Technology Limited, LLC (US), ZenBio, Inc. (US), Athena Environmental Sciences, Inc. (US), Cyagen Biosciences (US), Biowest SAS (France), WELGENE Inc.(South Korea), KCell Biosciences (South Korea), and Akron Biotech (US). Research Coverage: Reasons to Buy the Report The report provides insights on the following pointers: Browse our full report with Table of Content : Contact us at: © 2023 Kavita Krishna |
StatsAuthor
|
Share This
Email
Facebook
Twitter
Read Request
My Library
Subscribe
Flag Writing
